# Study in Healthy Volunteers to Establish the BioEquivalence of Two Formulations of BG00012

> **NCT01420458** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 80 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Experimental

## Key facts

- **NCT ID:** NCT01420458
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2011-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01420458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01420458, "Study in Healthy Volunteers to Establish the BioEquivalence of Two Formulations of BG00012". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01420458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*